Skip to content
The Mumbai

Jagsonpal Pharmaceuticals’ Q2 FY27 Consolidated Revenue Rises 29% To ₹964 Crore

Jagsonpal Pharmaceuticals’ Q2 FY27 Consolidated Revenue Rises 29% To ₹964 Crore
Photo: Free Press Journal · view original

Mumbai: Jagsonpal Pharmaceuticals Limited on Tuesday announced its unaudited financial results for the quarter and half year ended 30 September 2026, reporting a consolidated revenue increase of 29% to ₹964 crore for Q2 FY27. Standalone Performance For the standalone business, Q2 FY27 revenue fro...

Sources and story details